KMC Speciality Hospitals Intrinsic Value
KMC Speciality Hospitals (KMCSHIL) median intrinsic value is ₹131.25 from 9 valuation models (range ₹39–₹322), vs current price ₹128.90 — +1.8% upside (Trading Near Calculated Value), margin of safety 1.8%. Analyse KMCSHIL shareholding pattern to track promoter, FII and institutional holdings.
KMCSHIL Valuation Methods Summary — DCF, Graham Number & P/E
KMC Speciality Hospitals intrinsic value across 9 models vs current price ₹128.90 — upside/downside and value range per method. For current market price and key ratios, visit KMCSHIL share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹38.67 | ₹30.94 - ₹46.40 | -70.0% | EPS: ₹2.87, Sector P/E: 12x |
| Book Value Method | asset | ₹131.25 | ₹118.12 - ₹144.38 | +1.8% | Book Value/Share: ₹131.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹153.00 | ₹137.70 - ₹168.30 | +18.7% | Revenue/Share: ₹191.25, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹257.80 | ₹232.02 - ₹283.58 | +100.0% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹322.25 | ₹257.80 - ₹386.70 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹42.73 | ₹38.46 - ₹47.00 | -66.9% | EPS Growth: 18.6%, Fair P/E: 14.9x |
| Growth Adjusted P/E | growth | ₹38.67 | ₹34.80 - ₹42.54 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹257.80 | ₹232.02 - ₹283.58 | +100.0% | ROE: 22.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹92.06 | ₹82.85 - ₹101.27 | -28.6% | EPS: ₹2.87, BVPS: ₹131.25 |
KMCSHIL Intrinsic Value vs Market Price — All Valuation Models
KMC Speciality Hospitals fair value range ₹39–₹322 vs current market price ₹128.90 across 9 valuation models. Read KMCSHIL dividend yield for the complete payout history and dividend yield track record.
KMCSHIL Intrinsic Value Analysis — Undervalued or Overvalued?
KMC Speciality Hospitals median intrinsic value ₹131.25, current price ₹128.90 — Trading Near Calculated Value by 1.8%, margin of safety 1.8%.
What is the intrinsic value of KMCSHIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of KMC Speciality Hospitals (KMCSHIL) is ₹131.25 (median value). With the current market price of ₹128.90, this represents a +1.8% variance from our estimated fair value.
The valuation range spans from ₹38.67 to ₹322.25, indicating ₹38.67 - ₹322.25.
Is KMCSHIL undervalued or overvalued?
Based on our multi-method analysis, KMC Speciality Hospitals (KMCSHIL) appears to be trading near calculated value by approximately 1.8%.
KMCSHIL Financial Health — Key Ratios vs Industry Benchmarks
KMC Speciality Hospitals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.03 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 22.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.92x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KMCSHIL Cash Flow Quality — Operating & Free Cash Flow
KMC Speciality Hospitals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹58 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹38 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹32 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹29 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹26 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |